Compare Enveric Biosciences Inc (ENVB) vs State Street Real Estate Select Sector SPDR ETF (XLRE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs State Street Real Estate Select Sector SPDR ETF — how do they compare? Enveric Biosciences Inc trades at $1.37 (market cap $5.32M), while State Street Real Estate Select Sector SPDR ETF trades at $45.37. The key difference: State Street Real Estate Select Sector SPDR ETF is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | XLRE | |
|---|---|---|
Market Cap | $5.32M | — |
Sector | Health | Sector/Thematic |
52-Week High | $17.40 | $45.36 |
52-Week Low | $1.28 | $40.01 |
Enterprise Value | $408.82K | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.41, up 6.82% in the last session. The stock shows a bearish technical trend with moving averages signaling sell, but oscillators are neutral. Financially, the company reported a net loss of $8.77M for 2025, with negative ROE and ROA, though it consistently beat EPS expectations. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003.
Outlook is speculative with high risk due to negative profitability and cash burn, offset by strong analyst buy ratings (75%) and positive clinical updates. Key risks include funding needs and drug development hurdles, while catalysts hinge on regulatory milestones and partnership news.
XLRE, the Real Estate Select Sector SPDR ETF, trades at $44.93, up 1.01% on the day, with technical indicators signaling a bullish trend. The ETF has gained approximately 11% year-to-date, defying broader market pressures, as real estate fundamentals show resilience. Recent news highlights its low 0.08% expense ratio and steady 3.4% distribution yield, while technical analysis shows strong buy signals from moving averages and a neutral stance from oscillators.
The outlook for XLRE appears cautiously optimistic, supported by improving REIT fundamentals and a potential turning point in the sector's repricing cycle. Investment opportunities include exposure to a recovering real estate sector with low-cost efficiency, but risks persist from interest rate volatility, inflation pressures, and potential sector-wide pullbacks if bond yields rise further.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About State Street Real Estate Select Sector SPDR ETF
XLRE tracks the Real Estate Select Sector Index, providing exposure to S&P 500 real estate companies. It focuses on equity REITs across residential, industrial, and healthcare sub-sectors, with top holdings like Welltower, Prologis, and American Tower.
Read more on XLRE →
